A detailed history of Ubs Asset Management Americas Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 10,175,926 shares of ABBV stock, worth $1.82 Billion. This represents 0.53% of its overall portfolio holdings.

Number of Shares
10,175,926
Previous 9,592,973 6.08%
Holding current value
$1.82 Billion
Previous $1.65 Billion 22.13%
% of portfolio
0.53%
Previous 0.48%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $95.5 Million - $116 Million
582,953 Added 6.08%
10,175,926 $2.01 Billion
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $130 Million - $151 Million
838,012 Added 9.57%
9,592,973 $1.65 Billion
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $14.2 Million - $16.2 Million
-89,025 Reduced 1.01%
8,754,961 $1.59 Billion
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $77.4 Million - $87.1 Million
-562,261 Reduced 5.98%
8,843,986 $1.37 Billion
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $77.1 Million - $89.3 Million
-577,122 Reduced 5.78%
9,406,247 $1.4 Billion
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $114 Million - $131 Million
-786,314 Reduced 7.3%
9,983,369 $1.59 Billion
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $8.44 Million - $10.1 Million
-60,995 Reduced 0.56%
10,769,683 $1.74 Billion
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $24.3 Million - $27.8 Million
-180,708 Reduced 1.64%
10,830,678 $1.45 Billion
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $129 Million - $164 Million
938,091 Added 9.31%
11,011,386 $1.69 Billion
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $140 Million - $174 Million
-1,064,271 Reduced 9.56%
10,073,295 $1.63 Billion
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $118 Million - $149 Million
-1,096,380 Reduced 8.96%
11,137,566 $1.51 Billion
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $124 Million - $141 Million
1,166,720 Added 10.54%
12,233,946 $1.32 Billion
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $45.1 Million - $50.3 Million
-429,138 Reduced 3.73%
11,067,226 $1.25 Billion
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $5.92 Million - $6.51 Million
57,833 Added 0.51%
11,496,364 $1.24 Billion
Q4 2020

Mar 01, 2021

BUY
$80.49 - $108.67 $182 Million - $246 Million
2,263,374 Added 24.67%
11,438,531 $1.23 Billion
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $36.6 Million - $43 Million
426,045 Added 4.87%
9,175,157 $804 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $196 Million - $262 Million
2,666,133 Added 43.83%
8,749,112 $859 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $18.7 Million - $28.4 Million
290,574 Added 5.02%
6,082,979 $463 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $5.25 Million - $6.57 Million
-72,771 Reduced 1.24%
5,792,405 $513 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $8.92 Million - $10.7 Million
141,629 Added 2.47%
5,865,176 $444 Million
Q2 2019

Aug 15, 2019

SELL
$65.7 - $83.98 $269,567 - $344,569
-4,103 Reduced 0.07%
5,723,547 $0
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $12.9 Million - $15.2 Million
167,401 Added 3.01%
5,727,650 $0
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $2.74 Million - $3.38 Million
-35,240 Reduced 0.63%
5,560,249 $513 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $3.87 Million - $4.31 Million
-43,583 Reduced 0.77%
5,595,489 $0
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $24.9 Million - $29.4 Million
-277,013 Reduced 4.68%
5,639,072 $0
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $18.4 Million - $24.7 Million
200,298 Added 3.5%
5,916,085 $0
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $19 Million - $20.8 Million
-211,917 Reduced 3.58%
5,715,787 $0
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $414 Million - $529 Million
5,927,704
5,927,704 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.